aytubio.com (AYTU) Quarterly EPS earnings growth

Symbol and logo of brand aytubio.com (AYTU)

Steady demand for ADHD medications generates a consistent cash flow, supported by Aytu BioPharma's impeccable reputation among pediatricians. The quarterly growth rate of net income per share visualizes the market dynamics, where 100.40 shows the value of this parameter. Business protection is ensured by unique patents for orphan drugs and close ties with specialized professionals.

AYTU: Aytu BioPharma Year-over-year earnings per one share growth for the last 12 months 07/04/2022 - 11/16/2026

aytubio.com (AYTU) - metric breakdowns and financial figures

- share price and expert price forecast:
Initial company analysis:Aytu BioPharma, Inc.
Flagship merchandise of Aytu BioPharma, Inc.

This indicator measures the percentage change in net earnings per share between reporting periods, linking operational efficiency to market capitalization. The stable R&D pipeline of Aytu BioPharma (AYTU) in the pediatric drug sector minimizes earnings volatility, allowing investors to determine the real value of the business without market noise through the quarterly EPS growth metric.

Who Aytu BioPharma, Inc. competes with

VRTX: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Alnylam Inc. (ALNY)|INSM (Insmed) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months UTHR (United Therapeutics Corporation)|Year-over-year net earnings per share growth for the last 12 months BMRN (BioMarin)|BBIO (BridgeBio Pharma) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth BGM (BGM Group Ltd)|COGT (Cogent Bio) - Year-over-year net earnings per share trend for the last twelve months|Xeris Biopharma - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months KROS (Keros Therapeutics)|ARCT: Quarterly EPS earnings growth|Eton Pharmaceuticals Inc (ETON) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Kamada Corp|FULC: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Abeona Therapeutics, Inc. (ABEO)|Year-over-year net earnings per share growth for the last 12 months Mereo BioPharma Group plc MREO|Year-over-year earnings per share growth for the last twelve months Protalix BioTherapeutics PLX|Quarterly EPS earnings growth Pliant Therapeutics PLRX|appliedtherapeutics.com - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months RNTX (Rein Therapeutics, Inc.)|GELS: Quarterly EPS earnings growth|Chemomab Therapeutics Ltd - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months SRXH|Year-over-year earnings per share growth for the last twelve months PLRZ|Quarterly EPS earnings growth AEZS|Year-over-year earnings per share growth for the last twelve months CYTH (Cyclo Therapeutics, Inc)|Inozyme Pharma - Year-over-year net earnings per share growth for the last 12 months|Reneo Pharmaceuticals, Inc. (RPHM) - Earnings per share growth in annualized terms for the last twelve months|COSCIENS Bio - Quarterly EPS earnings growth